FdaApplication
ANDA 215217
Identifiers
- fda_app_no: ANDA215217
Properties
| Property | Value |
|---|---|
| applicant_name | NEPHRON PHARMACEUTICALS CORPORATION |
| application_type | ANDA |
| approval_date | 2026-05-26 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LEVALBUTEROL HYDROCHLORIDE | LEVALBUTEROL HYDROCHLORIDE | EQ 0.021% BASE | SOLUTION;INHALATION |
| LEVALBUTEROL HYDROCHLORIDE | LEVALBUTEROL HYDROCHLORIDE | EQ 0.042% BASE | SOLUTION;INHALATION |
2 products